Genvax
PrivateLast Round
Grant
Apr 23, 2025
Total Funding Raised
$6.92M
Momentum Score
25 /100
Company Overview
Genvax is an animal health company that develops self-amplifying mRNA (saRNA) vaccines designed to accelerate treatments for the animal health industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genvax Comps
Public and private peers based on sector, stage, and business model.
Genvax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 23, 2025 | ||||
| Seed | Feb 3, 2025 | ||||
| Seed | Aug 11, 2022 | ||||
| Grant | Apr 18, 2022 |
Genvax Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2025
$278K grant round completed.
- Apr 23, 2025
Developing an H5N1 vaccine for dairy cows with FFAR grant.
Genvax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genvax's valuation, stock price, and market status.
